The bone microenvironment in metastasis; what is special about bone?

[1]  S. Goldring.  Chapter 59. Inflammation‐Induced Bone Loss in the Rheumatic Diseases , 2009 .

[2]  J. Chirgwin,et al.  Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases , 2007, Cancer and Metastasis Reviews.

[3]  V. Glinsky.  Intravascular cell-to-cell adhesive interactions and bone metastasis , 2007, Cancer and Metastasis Reviews.

[4]  E. Vogler,et al.  Extended-term culture of bone cells in a compartmentalized bioreactor. , 2006, Tissue engineering.

[5]  K. Pantel,et al.  Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance. , 2006, Future oncology.

[6]  D. Sosnoski,et al.  Osteoblast‐conditioned media influence the expression of E‐selectin on bone‐derived vascular endothelial cells , 2006, Journal of cellular biochemistry.

[7]  Kathryn E Luker,et al.  Functions of CXCL12 and CXCR4 in breast cancer. , 2006, Cancer letters.

[8]  J. Chirgwin,et al.  New insights into the role of T cells in the vicious cycle of bone metastases , 2006, Current opinion in rheumatology.

[9]  A. Lucci,et al.  Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer. , 2006, The Journal of surgical research.

[10]  V. Cerundolo,et al.  Malignant melanoma and bone resorption , 2006, British Journal of Cancer.

[11]  Younghun Jung,et al.  Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. , 2006, Bone.

[12]  T. Glant,et al.  Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris. , 2006, Journal of biomedical materials research. Part A.

[13]  Y. Kadono,et al.  Osteoimmunology: interplay between the immune system and bone metabolism. , 2006, Annual review of immunology.

[14]  J. Kappes,et al.  Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone , 2006, Clinical Cancer Research.

[15]  Mary E. Choi,et al.  Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. , 2006, Cancer research.

[16]  J. Hopper,et al.  Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. , 2006, Cancer research.

[17]  Jianhua Wang,et al.  Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. , 2005, Cellular signalling.

[18]  J. Chirgwin,et al.  Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. , 2005, Cancer research.

[19]  T. Glant,et al.  Chemokine IL‐8 induction by particulate wear debris in osteoblasts is mediated by NF‐κB , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[20]  S. Aaronson,et al.  Prostate cancer cells promote osteoblastic bone metastases through Wnts. , 2005, Cancer research.

[21]  M. Chávez-MacGregor,et al.  Angiogenesis in the Bone Marrow of Patients with Breast Cancer , 2005, Clinical Cancer Research.

[22]  S. Colucci,et al.  Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  D. Yamaguchi,et al.  KC chemokine expression by TGF-β in C3H10T1/2 cells induced towards osteoblasts , 2005 .

[24]  P. Clézardin,et al.  Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. , 2004, The Journal of clinical investigation.

[25]  C. Furnival.  The Breast: Comprehensive Management of Benign and Malignant Disorders. , 2004 .

[26]  Abraham Schneider,et al.  Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  E. van Marck,et al.  Increased Serum Interleukin-8 in Patients with Early and Metastatic Breast Cancer Correlates with Early Dissemination and Survival , 2004, Clinical Cancer Research.

[28]  J. Westendorf,et al.  Wnt signaling in osteoblasts and bone diseases. , 2004, Gene.

[29]  D. Griggs,et al.  A small molecule antagonist of the αvβ3 integrin suppresses MDA-MB-435 skeletal metastasis , 2004, Clinical & Experimental Metastasis.

[30]  D. Noonan,et al.  CXCL1/Macrophage Inflammatory Protein-2-Induced Angiogenesis In Vivo Is Mediated by Neutrophil-Derived Vascular Endothelial Growth Factor-A1 , 2004, The Journal of Immunology.

[31]  G. Roodman.  Mechanisms of bone metastasis. , 2004, Discovery medicine.

[32]  D. Welch,et al.  Breast cancer cells induce osteoblast apoptosis: A possible contributor to bone degradation , 2004, Journal of cellular biochemistry.

[33]  A. Friedl,et al.  Induction of Syndecan-1 Expression in Stromal Fibroblasts Promotes Proliferation of Human Breast Cancer Cells , 2004, Cancer Research.

[34]  K. Pienta,et al.  Evidence of porcine and human endothelium activation by cancer‐associated carbohydrates expressed on glycoproteins and tumour cells , 2004, The Journal of physiology.

[35]  B. Shalmon,et al.  Progression of mouse mammary tumors: MCP‐1‐TNFα cross‐regulatory pathway and clonal expression of promalignancy and antimalignancy factors , 2003, International journal of cancer.

[36]  L. Suva,et al.  Breast cancer metastasis to bone: it is not all about PTHrP. , 2003, Clinical orthopaedics and related research.

[37]  J. Chirgwin,et al.  Transforming growth factor-beta in osteolytic breast cancer bone metastases. , 2003, Clinical orthopaedics and related research.

[38]  Puneeth Iyengar,et al.  Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization , 2003, Oncogene.

[39]  J. Chirgwin,et al.  A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Crispino,et al.  Effect of the Combination of Docetaxel, Zoledronic Acid, and a COX-2 Inhibitor on the Growth of Human Breast Cancer Cell Lines , 2003, American journal of clinical oncology.

[41]  L. Suva,et al.  Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. , 2003, Bone.

[42]  M. Dowsett,et al.  Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  W. Weichert,et al.  Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma , 2003, Cancer.

[44]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[45]  G. Glinsky,et al.  MDA-MB-435 Human Breast Carcinoma Cell Homo- and Heterotypic Adhesion under Flow Conditions Is Mediated in Part by Thomsen-Friedenreich Antigen-Galectin-3 Interactions* , 2003, The Journal of Biological Chemistry.

[46]  K. Mohammad,et al.  Role of endothelin‐1 in osteoblastic bone metastases , 2003, Cancer.

[47]  G. Rodan.  The development and function of the skeleton and bone metastases , 2003, Cancer.

[48]  G. Lisignoli,et al.  Different chemokines are expressed in human arthritic bone biopsies: IFN-gamma and IL-6 differently modulate IL-8, MCP-1 and rantes production by arthritic osteoblasts. , 2002, Cytokine.

[49]  L. Suva,et al.  Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. , 2002, Cancer research.

[50]  K. Alitalo,et al.  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.

[51]  T. Powles,et al.  Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[53]  N. Kieffer,et al.  Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  I. Witz,et al.  Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas. , 2002, Immunology letters.

[55]  R. Breyer,et al.  Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. , 2002, Bone.

[56]  G. Sukhikh,et al.  Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.

[57]  Paul J. Williams,et al.  Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. , 2002, Cancer research.

[58]  J. Isola,et al.  Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. , 2002, Cancer research.

[59]  P. Saftig,et al.  The Bone Lining Cell: Its Role in Cleaning Howship's Lacunae and Initiating Bone Formation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[60]  N. Olsen,et al.  Bone marrow stromal cells mediate androgenic suppression of B lymphocyte development. , 2001, The Journal of clinical investigation.

[61]  Qingyuan Yang,et al.  Increased cyclooxygenase‐2 (cox‐2) expression and activity in a murine model of metastatic breast cancer , 2001, International journal of cancer.

[62]  P. Lala,et al.  Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis , 2001, International journal of cancer.

[63]  G D Roodman,et al.  Biology of osteoclast activation in cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  S. Deutscher,et al.  The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. , 2001, Cancer research.

[65]  Paul J. Williams,et al.  The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. , 2001, Cancer research.

[66]  T. Hla,et al.  Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice* , 2001, The Journal of Biological Chemistry.

[67]  Y. Deyama,et al.  Inactivation of NF-κB Involved in Osteoblast Development through Interleukin-6 , 2001 .

[68]  T. Matsuguchi,et al.  Gene Expression of Osteoclast Differentiation Factor Is Induced by Lipopolysaccharide in Mouse Osteoblasts Via Toll-Like Receptors1 , 2001, The Journal of Immunology.

[69]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[70]  T. Martin,et al.  Mechanisms in the skeletal complications of breast cancer. , 2000, Endocrine-related cancer.

[71]  Paul J. Williams,et al.  Cell–cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1-integrin enhances production of osteoclast-stimulating activity , 2000 .

[72]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[73]  T. Guise.  Molecular mechanisms of osteolytic bone metastases , 2000, Cancer.

[74]  C. Carron,et al.  Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone. , 2000, The Journal of endocrinology.

[75]  S. Deutscher,et al.  Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. , 2000, Cancer research.

[76]  P. Delmas,et al.  Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. , 2000, Bone.

[77]  Matthew J. Silva,et al.  Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength , 2000, The Journal of cell biology.

[78]  R. Rubens,et al.  Cancer and the Skeleton , 2000 .

[79]  M. Kuwano,et al.  Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: Possible involvement of TNFα and IL‐1α , 2000 .

[80]  M. Oursler,et al.  Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. , 1999, Cancer research.

[81]  H. Augustin,et al.  Induction of inflammatory angiogenesis by monocyte chemoattractant protein‐1 , 1999, International journal of cancer.

[82]  I. Mazo,et al.  Adhesion and homing of blood‐borne cells in bone marrow microvessels , 1999, Journal of leukocyte biology.

[83]  A. J. Valente,et al.  The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts. , 1999, Frontiers in bioscience : a journal and virtual library.

[84]  G. Turner,et al.  Are selectins involved in metastasis? , 1999, Clinical & Experimental Metastasis.

[85]  Guo‐Jun Zhang,et al.  Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. , 1999, Anticancer Research.

[86]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[87]  L. Chaudhary,et al.  Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. , 1998, Endocrinology.

[88]  V. Quaranta,et al.  Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin. , 1998, Biochemical and biophysical research communications.

[89]  Masahiko Kuroda,et al.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.

[90]  T. Guise,et al.  Cancer and bone. , 1998, Endocrine reviews.

[91]  K. Pienta,et al.  Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. , 1998, Journal of the National Cancer Institute.

[92]  J. Kanis,et al.  Bone turnover and biochemical markers in malignancy , 1997, Cancer.

[93]  A. Lipton.  Bisphosphonates and breast carcinoma , 1997, Cancer.

[94]  Rodger P McEver,et al.  Selectin-carbohydrate interactions during inflammation and metastasis , 1997, Glycoconjugate Journal.

[95]  J. Hoxie,et al.  The chemokine SDF‐1, stromal cell‐derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4 , 1997, European journal of immunology.

[96]  J. Compston,et al.  Principles of Bone Biology , 1997 .

[97]  T. Tsuruo,et al.  Stimulation of interleukin‐11 production from osteoblast‐like cells by transforming growth factor‐β and tumor cell factors , 1997, International journal of cancer.

[98]  J. Puzas,et al.  Osteoclasts constitutively express regulators of bone resorption: an immunohistochemical and in situ hybridization study. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[99]  R. Ziegler,et al.  Endothelin-1 Is a Potent Regulator of Human Bone Cell Metabolism In Vitro , 1997, Calcified Tissue International.

[100]  Lesline P.Gartner,et al.  Color Textbook of Histology , 1997 .

[101]  B F Boyce,et al.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.

[102]  T. Springer,et al.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) , 1996, The Journal of experimental medicine.

[103]  S. Nishikawa,et al.  Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 , 1996, Nature.

[104]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[105]  P. Allavena,et al.  Chemokines: a superfamily of chemotactic cytokines , 1996, International journal of clinical & laboratory research.

[106]  T. Yoneda,et al.  Mechanisms of preferential metastasis of breast cancer to bone - (Review). , 1996, International journal of oncology.

[107]  S. Kitazawa,et al.  Integrin αvβ3 Expression by Bone‐residing Breast Cancer Metastases , 1996 .

[108]  S. Kitazawa,et al.  Integrin alpha V beta 3 expression by bone-residing breast cancer metastases. , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[109]  N. Udagawa,et al.  Interleukin‐6 and soluble interleukin‐6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast‐like cell formation , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[110]  J. Buckwalter.  Pharmacological treatment of soft-tissue injuries. , 1995, The Journal of bone and joint surgery. American volume.

[111]  J. Nelson,et al.  Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate , 1995, Nature Medicine.

[112]  B F Boyce,et al.  Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. , 1995, Cancer research.

[113]  S. Manolagas,et al.  Role of cytokines in bone resorption. , 1995, Bone.

[114]  R. Thorpe.  Book reviewThe cytokine facts book: Callard, R. and Gearing A., vii + 265 pp. academic Press, London, 1994. Paperback GBP 19.50, ISBN 0-12-155143-1 , 1995 .

[115]  S. Schultz-Cherry,et al.  Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. , 1994, The Journal of biological chemistry.

[116]  L. Chaudhary,et al.  Dexamethasone regulates IL-1β and TNF-α-induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells , 1994, Calcified Tissue International.

[117]  G. Passeri,et al.  Interleukin-11: a new cytokine critical for osteoclast development. , 1994, The Journal of clinical investigation.

[118]  J A Kanis,et al.  Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. , 1994, Bone.

[119]  H. Dockrell.  The Cytokine Handbook , 1993 .

[120]  A. Mantovani,et al.  Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells , 1992, The Journal of experimental medicine.

[121]  G. Passeri,et al.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. , 1992, The Journal of clinical investigation.

[122]  T. Linkhart,et al.  Interleukin‐6 messenger RNA expression and interleukin‐6 protein secretion in cells isolated from normal human bone: Regulation by interleukin‐1 , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[123]  T. Hirano,et al.  IL-6 is produced by osteoblasts and induces bone resorption. , 1990, Journal of immunology.

[124]  S. Paget.  The distribution of secondary growths in cancer of the breast. 1889. , 1989, Cancer metastasis reviews.

[125]  T. Rosol,et al.  Quantitative bone histomorphometry in nude mice bearing a human squamous cell lung cancer , 1988, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[126]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[127]  M. Klagsbrun,et al.  Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. , 1986, The Journal of biological chemistry.

[128]  P. Delmas,et al.  Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry. , 1986, The Journal of clinical investigation.

[129]  C S Galasko,et al.  Mechanisms of lytic and blastic metastatic disease of bone. , 1982, Clinical orthopaedics and related research.

[130]  R. Baron,et al.  Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. , 1982, The Journal of clinical endocrinology and metabolism.

[131]  J. Ogden,et al.  Quantitation of regional chondro-osseous circulation in canine tibia and femur. , 1982, The American journal of physiology.

[132]  D. Rowe,et al.  Collagen and collagen-derived fragments are chemotactic for tumor cells. , 1981, The Journal of clinical investigation.

[133]  P. Ward,et al.  Chemotactic responses of tumor cells to products of resorbing bone. , 1979, Science.

[134]  G. Glick,et al.  The splanchnic circulation. , 1977, Modern concepts of cardiovascular disease.

[135]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[136]  R. E. Hungate,et al.  Yolk Sac Cultivation of Tumors , 1943 .

[137]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[138]  A. Mastro,et al.  Metastatic breast cancer induces an osteoblast inflammatory response. , 2008, Experimental cell research.

[139]  J. Degen,et al.  Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.

[140]  C. Brigati,et al.  Tumors and inflammatory infiltrates: Friends or foes? , 2004, Clinical & Experimental Metastasis.

[141]  A. Mastro,et al.  Metastatic breast cancer cells suppress osteoblast adhesion and differentiation , 2004, Clinical & Experimental Metastasis.

[142]  D. Welch,et al.  The skeleton as a unique environment for breast cancer cells , 2004, Clinical & Experimental Metastasis.

[143]  K. Pienta,et al.  The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestosterone and cytokines , 2004, Clinical & Experimental Metastasis.

[144]  T. Yoneda,et al.  Osteolytic bone metastasis in breast cancer , 2004, Breast Cancer Research and Treatment.

[145]  A. Angeli,et al.  Effects of physiological concentrations of steroid hormones and interleukin-11 on basal and stimulated production of interleukin-8 by human osteoblast-like cells with different functional profiles. , 2004, Clinical and experimental rheumatology.

[146]  K. Bland,et al.  The breast : comprehensive management of benign and malignant disorders , 2004 .

[147]  D. Griggs,et al.  A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. , 2004, Clinical & experimental metastasis.

[148]  P. Odgren,et al.  Chapter 1 – Structure and Development of the Skeleton , 2002 .

[149]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[150]  C. Overall,et al.  Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. , 2002, Cancer research.

[151]  M. Horton,et al.  Integrins and Other Cell Surface Attachment Molecules of Bone Cells , 2002 .

[152]  N. Udagawa,et al.  Cells of BoneOsteoclast Generation , 2002 .

[153]  N. Hynes,et al.  Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. , 2001, Cancer research.

[154]  T. Yoneda.  Cellular and molecular basis of preferential metastasis of breast cancer to bone , 2000, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[155]  John P. Bilezikian,et al.  Principles of Bone Biology , 1996 .

[156]  Paul,et al.  Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. , 1996, Blood.

[157]  G. Passeri,et al.  Estrogens, cytokines, and the pathophysiology of osteoporosis , 1994 .

[158]  J. Price,et al.  The cell biology of bone growth. , 1994, European journal of clinical nutrition.

[159]  A. Sasaki,et al.  Osteolysis and tumor growth are enhanced in sites of increased bone turnover in vivo. (口答発表) , 1994 .

[160]  A. Thomson.  The cytokine handbook , 1994 .

[161]  L. Chaudhary,et al.  Dexamethasone regulates IL-1 beta and TNF-alpha-induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells. , 1994, Calcified tissue international.

[162]  W. H. Howell.  Textbook of Physiology , 1989 .

[163]  N. Hancox.  Biology of bone , 1972 .

[164]  O. V. Batson.  THE RÔLE OF THE VERTEBRAL VEINS IN METASTATIC PROCESSES , 1942 .

[165]  N. Clarke,et al.  bone marrow endothelium: binding , 2022 .